Trinity Biotech stock trades after hours on Nasdaq

Trinity Biotech stock traded at 6.26 US dollars on Nasdaq at 10:00 p.m. Berlin time on Friday, October 30, 2026. The quote was recorded in after-hours trading. A Trinity Biotech Investor Relations overview describes the company as a commercial-stage biotechnology business focused on diabetes management and human diagnostics.

Diagnostics And Biosensor Expansion

Trinity Biotech develops, manufactures and markets diagnostic systems for point-of-care and clinical laboratory applications. Its products include reagents and instruments used to detect infectious diseases and measure haemoglobin A1c and other chemistry parameters in blood samples.

The company has also entered wearable biosensors through the acquisition of assets from WaveForm Technologies. Its stated development focus includes a continuous glucose monitoring product and related services, linking its diagnostics activities with diabetes management.

International Commercial Reach

Trinity Biotech sells directly in the United States and works with international distributors and strategic partners across more than 100 countries. That model gives the company a broad geographic route to market while keeping its product focus concentrated on diagnostics and biosensing.

Company Profile

Trinity Biotech is headquartered in Ireland and operates in human diagnostics and wearable biosensors. Its main activities cover point-of-care testing, clinical laboratory systems, infectious-disease detection and diabetes-related monitoring. The company occupies a specialist position within healthcare technology, combining established diagnostic products with an expansion into continuous glucose monitoring.

For investors, the next focus is the execution of the biosensor strategy alongside the existing diagnostics business. The real-time quote of Trinity Biotech stock remains the relevant reference for the latest Nasdaq trading indication.

Broader sentiment in US equities can be followed through the S&P 500 market environment.

More news and analyses on Trinity Biotech stock provide further company and market context.